Repligen
RGEN
#2399
Rank
HK$60.81 B
Marketcap
HK$1,078
Share price
-6.48%
Change (1 day)
10.43%
Change (1 year)
Categories

Repligen (RGEN) - Net assets

Net assets on the balance sheet as of March 2026 : HK$16.51 Billion

According to Repligen 's latest financial reports the company has HK$16.51 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Repligen - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$HK$16.38 B7%
2024-12-31$HK$15.31 B-0.2%
2023-12-31$HK$15.34 B2.79%
2022-12-31$HK$14.92 B9.4%
2021-12-31$HK$13.64 B15.12%
2020-12-31$HK$11.85 B43.63%
2019-12-31$HK$8.25 B71.22%
2018-12-31$HK$4.82 B4.3%
2017-12-31$HK$4.62 B253.16%
2016-12-31$HK$1.30 B37.56%
2015-12-31$HK$0.95 B9.78%
2014-12-31$HK$0.86 B7.58%
2013-12-31$HK$0.80 B23.54%
2012-12-31$HK$0.65 B
2011-03-31$HK$0.52 B1.62%
2010-03-31$HK$0.51 B-4.14%
2009-03-31$HK$0.53 B7.39%
2008-03-31$HK$0.49 B150%
2007-03-31$HK$0.19 B0.69%
2006-03-31$HK$0.19 B4.65%
2005-03-31$HK$0.18 B-10.47%
2004-03-31$HK$0.21 B10.45%
2003-03-31$HK$0.19 B-7.17%
2002-03-31$HK$0.20 B-14.38%
2001-03-31$HK$0.24 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
HK$708.93 B 4,193.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$408.25 B 2,372.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$143.48 B 769.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$157.63 B 854.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$48.95 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-HK$1.14 Billion-106.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$26.72 B 61.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$16.35 B-0.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$48.71 B 195.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$23.43 B 41.93%๐Ÿ‡บ๐Ÿ‡ธ USA